Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1997 Aug 1;100(3):639–648. doi: 10.1172/JCI119575

Stimulation of activin A expression in rat aortic smooth muscle cells by thrombin and angiotensin II correlates with neointimal formation in vivo.

J E Pawlowski 1, D S Taylor 1, M Valentine 1, M E Hail 1, P Ferrer 1, M C Kowala 1, C J Molloy 1
PMCID: PMC508232  PMID: 9239411

Abstract

Vasoactive GTP-binding protein-coupled receptor agonists (e.g., angiotensin II [AII] and alpha-thrombin) stimulate the production of mitogenic factors from vascular smooth muscle cells. In experiments to identify mitogens secreted from AII- or alpha-thrombin-stimulated rat aortic smooth muscle (RASM) cells, neutralizing antibodies directed against several growth factors (e.g., PDGF and basic fibroblast growth factor [basic FGF]) failed to inhibit the mitogenic activity of conditioned media samples derived from the cells. In this report, we found that polyclonal neutralizing antibodies directed against purified human placental basic FGF reduced the mitogenic activity of AII-stimulated RASM cell-conditioned media and in immunoblot experiments identified a 26-kD protein (14 kD under reducing conditions) that was distinct from basic FGF. After purification from RASM cell-conditioned medium, amino acid sequence analysis identified the protein as activin A, a member of the TGF-beta superfamily. Increased activin A expression was observed after treatment of the RASM cells with AII, alpha-thrombin, and the protein kinase C agonist PMA. In contrast, PDGF-BB or serum caused only a minor induction of this protein. Although activin A alone only weakly stimulated RASM cell DNA synthesis, it demonstrated a potent comitogenic effect in combination with either EGF or heparin-binding EGF-like growth factor in the RASM cells, increasing DNA synthesis by up to fourfold. Furthermore, in a rat carotid injury model, activin A mRNA was upregulated within 6 h after injury followed by increases in immunoreactive protein detected in the expanding neointima 7 and 14 d later. Taken together, these results indicate that activin A is a vascular smooth muscle cell-derived factor induced by vasoactive agonists that may, either alone or in combination with other vascular derived growth factors, have a role in neointimal formation after arterial injury.

Full Text

The Full Text of this article is available as a PDF (497.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bailey W. L., LaFleur D. W., Forrester J. S., Fagin J. A., Sharifi B. G. Stimulation of rat vascular smooth muscle cell glycosaminoglycan production by angiotensin II. Atherosclerosis. 1994 Nov;111(1):55–64. doi: 10.1016/0021-9150(94)90191-0. [DOI] [PubMed] [Google Scholar]
  2. Bennett M. R., Evan G. I., Schwartz S. M. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J Clin Invest. 1995 May;95(5):2266–2274. doi: 10.1172/JCI117917. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bennett M. R., Evan G. I., Schwartz S. M. Apoptosis of rat vascular smooth muscle cells is regulated by p53-dependent and -independent pathways. Circ Res. 1995 Aug;77(2):266–273. doi: 10.1161/01.res.77.2.266. [DOI] [PubMed] [Google Scholar]
  4. Berk B. C., Taubman M. B., Cragoe E. J., Jr, Fenton J. W., 2nd, Griendling K. K. Thrombin signal transduction mechanisms in rat vascular smooth muscle cells. Calcium and protein kinase C-dependent and -independent pathways. J Biol Chem. 1990 Oct 5;265(28):17334–17340. [PubMed] [Google Scholar]
  5. Border W. A., Ruoslahti E. Transforming growth factor-beta in disease: the dark side of tissue repair. J Clin Invest. 1992 Jul;90(1):1–7. doi: 10.1172/JCI115821. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Carney D. H., Mann R., Redin W. R., Pernia S. D., Berry D., Heggers J. P., Hayward P. G., Robson M. C., Christie J., Annable C. Enhancement of incisional wound healing and neovascularization in normal rats by thrombin and synthetic thrombin receptor-activating peptides. J Clin Invest. 1992 May;89(5):1469–1477. doi: 10.1172/JCI115737. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  8. Delafontaine P., Anwar A., Lou H., Ku L. G-protein coupled and tyrosine kinase receptors: evidence that activation of the insulin-like growth factor I receptor is required for thrombin-induced mitogenesis of rat aortic smooth muscle cells. J Clin Invest. 1996 Jan 1;97(1):139–145. doi: 10.1172/JCI118381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Esch F. S., Shimasaki S., Cooksey K., Mercado M., Mason A. J., Ying S. Y., Ueno N., Ling N. Complementary deoxyribonucleic acid (cDNA) cloning and DNA sequence analysis of rat ovarian inhibins. Mol Endocrinol. 1987 May;1(5):388–396. doi: 10.1210/mend-1-5-388. [DOI] [PubMed] [Google Scholar]
  10. Ferrer P., Valentine M., Jenkins-West T., Weber H., Goller N. L., Durham S. K., Molloy C. J., Moreland S. Orally active endothelin receptor antagonist BMS-182874 suppresses neointimal development in balloon-injured rat carotid arteries. J Cardiovasc Pharmacol. 1995 Dec;26(6):908–915. doi: 10.1097/00005344-199512000-00009. [DOI] [PubMed] [Google Scholar]
  11. Giachelli C., Bae N., Lombardi D., Majesky M., Schwartz S. Molecular cloning and characterization of 2B7, a rat mRNA which distinguishes smooth muscle cell phenotypes in vitro and is identical to osteopontin (secreted phosphoprotein I, 2aR). Biochem Biophys Res Commun. 1991 Jun 14;177(2):867–873. doi: 10.1016/0006-291x(91)91870-i. [DOI] [PubMed] [Google Scholar]
  12. Hakovirta H., Kaipia A., Söder O., Parvinen M. Effects of activin-A, inhibin-A, and transforming growth factor-beta 1 on stage-specific deoxyribonucleic acid synthesis during rat seminiferous epithelial cycle. Endocrinology. 1993 Oct;133(4):1664–1668. doi: 10.1210/endo.133.4.8404607. [DOI] [PubMed] [Google Scholar]
  13. Hashimoto M., Shoda A., Inoue S., Yamada R., Kondo T., Sakurai T., Ueno N., Muramatsu M. Functional regulation of osteoblastic cells by the interaction of activin-A with follistatin. J Biol Chem. 1992 Mar 5;267(7):4999–5004. [PubMed] [Google Scholar]
  14. Hedger M. P., Drummond A. E., Robertson D. M., Risbridger G. P., de Kretser D. M. Inhibin and activin regulate [3H]thymidine uptake by rat thymocytes and 3T3 cells in vitro. Mol Cell Endocrinol. 1989 Jan;61(1):133–138. doi: 10.1016/0303-7207(89)90198-6. [DOI] [PubMed] [Google Scholar]
  15. Herbert J. M., Lamarche I., Dol F. Induction of vascular smooth muscle cell growth by selective activation of the thrombin receptor. Effect of heparin. FEBS Lett. 1992 Apr 20;301(2):155–158. doi: 10.1016/0014-5793(92)81237-g. [DOI] [PubMed] [Google Scholar]
  16. Heyndrickx G. R. Angiotensin-converting enzyme inhibitor in a human model of restenosis. MERCATOR ("Multicenter European Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis") Study Group. Basic Res Cardiol. 1993;88 (Suppl 1):169–182. [PubMed] [Google Scholar]
  17. Huang C. L., Ives H. E. Growth inhibition by protein kinase C late in mitogenesis. 1987 Oct 29-Nov 4Nature. 329(6142):849–850. doi: 10.1038/329849a0. [DOI] [PubMed] [Google Scholar]
  18. Hübner G., Hu Q., Smola H., Werner S. Strong induction of activin expression after injury suggests an important role of activin in wound repair. Dev Biol. 1996 Feb 1;173(2):490–498. doi: 10.1006/dbio.1996.0042. [DOI] [PubMed] [Google Scholar]
  19. Inoue S., Orimo A., Hosoi T., Ikegami A., Kozaki K., Ouchi Y., Nomura S., Muramatsu M., Orimo H. Demonstration of activin-A in arteriosclerotic lesions. Biochem Biophys Res Commun. 1994 Nov 30;205(1):441–448. doi: 10.1006/bbrc.1994.2685. [DOI] [PubMed] [Google Scholar]
  20. Itoh H., Mukoyama M., Pratt R. E., Gibbons G. H., Dzau V. J. Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. J Clin Invest. 1993 May;91(5):2268–2274. doi: 10.1172/JCI116454. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Kanthou C., Benzakour O., Patel G., Deadman J., Kakkar V. V., Lupu F. Thrombin receptor activating peptide (TRAP) stimulates mitogenesis, c-fos and PDGF-A gene expression in human vascular smooth muscle cells. Thromb Haemost. 1995 Nov;74(5):1340–1347. [PubMed] [Google Scholar]
  22. Kojima I., Mogami H., Kawamura N., Yasuda H., Shibata H. Modulation of growth of vascular smooth muscle cells by activin A. Exp Cell Res. 1993 May;206(1):152–156. doi: 10.1006/excr.1993.1131. [DOI] [PubMed] [Google Scholar]
  23. Kotajima A., Miyamoto Y., Tsuruo M., Kosaka M., Saito S. Effects of activin A on deoxyribonucleic acid synthesis, iodine metabolism, and cyclic adenosine monophosphate accumulation in porcine thyroid cells. Endocrinology. 1995 Mar;136(3):1214–1218. doi: 10.1210/endo.136.3.7867575. [DOI] [PubMed] [Google Scholar]
  24. Marrero M. B., Schieffer B., Paxton W. G., Duff J. L., Berk B. C., Bernstein K. E. The role of tyrosine phosphorylation in angiotensin II-mediated intracellular signalling. Cardiovasc Res. 1995 Oct;30(4):530–536. [PubMed] [Google Scholar]
  25. Massagué J. The TGF-beta family of growth and differentiation factors. Cell. 1987 May 22;49(4):437–438. doi: 10.1016/0092-8674(87)90443-0. [DOI] [PubMed] [Google Scholar]
  26. Matsuse T., Ikegami A., Ohga E., Hosoi T., Oka T., Kida K., Fukayama M., Inoue S., Nagase T., Ouchi Y. Expression of immunoreactive activin A protein in remodeling lesions associated with interstitial pulmonary fibrosis. Am J Pathol. 1996 Mar;148(3):707–713. [PMC free article] [PubMed] [Google Scholar]
  27. McCarthy S. A., Bicknell R. Inhibition of vascular endothelial cell growth by activin-A. J Biol Chem. 1993 Nov 5;268(31):23066–23071. [PubMed] [Google Scholar]
  28. McNamara C. A., Sarembock I. J., Gimple L. W., Fenton J. W., 2nd, Coughlin S. R., Owens G. K. Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor. J Clin Invest. 1993 Jan;91(1):94–98. doi: 10.1172/JCI116206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Miyagawa J., Higashiyama S., Kawata S., Inui Y., Tamura S., Yamamoto K., Nishida M., Nakamura T., Yamashita S., Matsuzawa Y. Localization of heparin-binding EGF-like growth factor in the smooth muscle cells and macrophages of human atherosclerotic plaques. J Clin Invest. 1995 Jan;95(1):404–411. doi: 10.1172/JCI117669. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Molloy C. J., Pawlowski J. E., Taylor D. S., Turner C. E., Weber H., Peluso M. Thrombin receptor activation elicits rapid protein tyrosine phosphorylation and stimulation of the raf-1/MAP kinase pathway preceding delayed mitogenesis in cultured rat aortic smooth muscle cells: evidence for an obligate autocrine mechanism promoting cell proliferation induced by G-protein-coupled receptor agonist. J Clin Invest. 1996 Mar 1;97(5):1173–1183. doi: 10.1172/JCI118531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Molloy C. J., Taylor D. S., Weber H. Angiotensin II stimulation of rapid protein tyrosine phosphorylation and protein kinase activation in rat aortic smooth muscle cells. J Biol Chem. 1993 Apr 5;268(10):7338–7345. [PubMed] [Google Scholar]
  32. Naftilan A. J., Pratt R. E., Dzau V. J. Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells. J Clin Invest. 1989 Apr;83(4):1419–1424. doi: 10.1172/JCI114032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Nishihara T., Okahashi N., Ueda N. Activin A induces apoptotic cell death. Biochem Biophys Res Commun. 1993 Dec 15;197(2):985–991. doi: 10.1006/bbrc.1993.2576. [DOI] [PubMed] [Google Scholar]
  34. Petraglia F., Sacerdote P., Cossarizza A., Angioni S., Genazzani A. D., Franceschi C., Muscettola M., Grasso G. Inhibin and activin modulate human monocyte chemotaxis and human lymphocyte interferon-gamma production. J Clin Endocrinol Metab. 1991 Feb;72(2):496–502. doi: 10.1210/jcem-72-2-496. [DOI] [PubMed] [Google Scholar]
  35. Petraglia F., Sawchenko P., Lim A. T., Rivier J., Vale W. Localization, secretion, and action of inhibin in human placenta. Science. 1987 Jul 10;237(4811):187–189. doi: 10.1126/science.3299703. [DOI] [PubMed] [Google Scholar]
  36. Powell J. S., Rouge M., Müller R. K., Baumgartner H. R. Cilazapril suppresses myointimal proliferation after vascular injury: effects on growth factor induction in vascular smooth muscle cells. Basic Res Cardiol. 1991;86 (Suppl 1):65–74. [PubMed] [Google Scholar]
  37. Roberts A. B., McCune B. K., Sporn M. B. TGF-beta: regulation of extracellular matrix. Kidney Int. 1992 Mar;41(3):557–559. doi: 10.1038/ki.1992.81. [DOI] [PubMed] [Google Scholar]
  38. Roberts A. B., Sporn M. B., Assoian R. K., Smith J. M., Roche N. S., Wakefield L. M., Heine U. I., Liotta L. A., Falanga V., Kehrl J. H. Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci U S A. 1986 Jun;83(12):4167–4171. doi: 10.1073/pnas.83.12.4167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Roberts A. B. Transforming growth factor-beta: activity and efficacy in animal models of wound healing. Wound Repair Regen. 1995 Oct–Dec;3(4):408–418. doi: 10.1046/j.1524-475X.1995.30405.x. [DOI] [PubMed] [Google Scholar]
  40. Rossi M. J., Chegini N., Masterson B. J. Presence of epidermal growth factor, platelet-derived growth factor, and their receptors in human myometrial tissue and smooth muscle cells: their action in smooth muscle cells in vitro. Endocrinology. 1992 Mar;130(3):1716–1727. doi: 10.1210/endo.130.3.1311246. [DOI] [PubMed] [Google Scholar]
  41. Sakurai T., Abe Y., Kasuya Y., Takuwa N., Shiba R., Yamashita T., Endo T., Goto K. Activin A stimulates mitogenesis in Swiss 3T3 fibroblasts without activation of mitogen-activated protein kinases. J Biol Chem. 1994 May 13;269(19):14118–14122. [PubMed] [Google Scholar]
  42. Sambhi M. P., Swaminathan N., Wang H., Rong H. Increased EGF binding and EGFR mRNA expression in rat aorta with chronic administration of pressor angiotensin II. Biochem Med Metab Biol. 1992 Aug;48(1):8–18. doi: 10.1016/0885-4505(92)90042-w. [DOI] [PubMed] [Google Scholar]
  43. Scott-Burden T., Hahn A. W., Resink T. J., Bühler F. R. Modulation of extracellular matrix by angiotensin II: stimulated glycoconjugate synthesis and growth in vascular smooth muscle cells. J Cardiovasc Pharmacol. 1990;16 (Suppl 4):S36–S41. [PubMed] [Google Scholar]
  44. Serruys P. W., Herrman J. P., Simon R., Rutsch W., Bode C., Laarman G. J., van Dijk R., van den Bos A. A., Umans V. A., Fox K. A. A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty. Helvetica Investigators. N Engl J Med. 1995 Sep 21;333(12):757–763. doi: 10.1056/NEJM199509213331203. [DOI] [PubMed] [Google Scholar]
  45. Sharifi B. G., LaFleur D. W., Pirola C. J., Forrester J. S., Fagin J. A. Angiotensin II regulates tenascin gene expression in vascular smooth muscle cells. J Biol Chem. 1992 Nov 25;267(33):23910–23915. [PubMed] [Google Scholar]
  46. Smith J. C., Price B. M., Van Nimmen K., Huylebroeck D. Identification of a potent Xenopus mesoderm-inducing factor as a homologue of activin A. Nature. 1990 Jun 21;345(6277):729–731. doi: 10.1038/345729a0. [DOI] [PubMed] [Google Scholar]
  47. Smith S. C., Jr AHA president's letter. Circulation. 1995 Jul 1;92(1):1–1. [PubMed] [Google Scholar]
  48. Stouffer G. A., Sarembock I. J., McNamara C. A., Gimple L. W., Owens G. K. Thrombin-induced mitogenesis of vascular SMC is partially mediated by autocrine production of PDGF-AA. Am J Physiol. 1993 Sep;265(3 Pt 1):C806–C811. doi: 10.1152/ajpcell.1993.265.3.C806. [DOI] [PubMed] [Google Scholar]
  49. Sung C. P., Arleth A. J., Storer B. L., Ohlstein E. H. Angiotensin type 1 receptors mediate smooth muscle proliferation and endothelin biosynthesis in rat vascular smooth muscle. J Pharmacol Exp Ther. 1994 Oct;271(1):429–437. [PubMed] [Google Scholar]
  50. Temizer D. H., Yoshizumi M., Perrella M. A., Susanni E. E., Quertermous T., Lee M. E. Induction of heparin-binding epidermal growth factor-like growth factor mRNA by phorbol ester and angiotensin II in rat aortic smooth muscle cells. J Biol Chem. 1992 Dec 5;267(34):24892–24896. [PubMed] [Google Scholar]
  51. Van Obberghen-Schilling E., Pouysségur J. Signaling pathways of the thrombin receptor. Thromb Haemost. 1993 Jul 1;70(1):163–167. [PubMed] [Google Scholar]
  52. Weber H., Taylor D. S., Molloy C. J. Angiotensin II induces delayed mitogenesis and cellular proliferation in rat aortic smooth muscle cells. Correlation with the expression of specific endogenous growth factors and reversal by suramin. J Clin Invest. 1994 Feb;93(2):788–798. doi: 10.1172/JCI117033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Weber H., Webb M. L., Serafino R., Taylor D. S., Moreland S., Norman J., Molloy C. J. Endothelin-1 and angiotensin-II stimulate delayed mitogenesis in cultured rat aortic smooth muscle cells: evidence for common signaling mechanisms. Mol Endocrinol. 1994 Feb;8(2):148–158. doi: 10.1210/mend.8.2.8170471. [DOI] [PubMed] [Google Scholar]
  54. Weiss R. H., Maduri M. The mitogenic effect of thrombin in vascular smooth muscle cells is largely due to basic fibroblast growth factor. J Biol Chem. 1993 Mar 15;268(8):5724–5727. [PubMed] [Google Scholar]
  55. Wolf Y. G., Rasmussen L. M., Ruoslahti E. Antibodies against transforming growth factor-beta 1 suppress intimal hyperplasia in a rat model. J Clin Invest. 1994 Mar;93(3):1172–1178. doi: 10.1172/JCI117070. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Woodruff T. K., Meunier H., Jones P. B., Hsueh A. J., Mayo K. E. Rat inhibin: molecular cloning of alpha- and beta-subunit complementary deoxyribonucleic acids and expression in the ovary. Mol Endocrinol. 1987 Aug;1(8):561–568. doi: 10.1210/mend-1-8-561. [DOI] [PubMed] [Google Scholar]
  57. Yasuda H., Mine T., Shibata H., Eto Y., Hasegawa Y., Takeuchi T., Asano S., Kojima I. Activin A: an autocrine inhibitor of initiation of DNA synthesis in rat hepatocytes. J Clin Invest. 1993 Sep;92(3):1491–1496. doi: 10.1172/JCI116727. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Ying S. Y. Inhibins, activins, and follistatins: gonadal proteins modulating the secretion of follicle-stimulating hormone. Endocr Rev. 1988 May;9(2):267–293. doi: 10.1210/edrv-9-2-267. [DOI] [PubMed] [Google Scholar]
  59. Yu J., Shao L. E., Lemas V., Yu A. L., Vaughan J., Rivier J., Vale W. Importance of FSH-releasing protein and inhibin in erythrodifferentiation. Nature. 1987 Dec 24;330(6150):765–767. doi: 10.1038/330765a0. [DOI] [PubMed] [Google Scholar]
  60. van den Eijnden-Van Raaij A. J., van Zoelent E. J., van Nimmen K., Koster C. H., Snoek G. T., Durston A. J., Huylebroeck D. Activin-like factor from a Xenopus laevis cell line responsible for mesoderm induction. Nature. 1990 Jun 21;345(6277):732–734. doi: 10.1038/345732a0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES